GeneTex
United States (US)

FGF9 recombinant protein

Cat No. GTX65412

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Mouse
Species Mouse
APPLICATION

Application Note

The recombinant rat FGF-9 is fully biologically active when compared to standards. The ED50, determined by the dose-dependent proliferation of BAF3 cells expressing FGF receptors is <0.5 ng/ml.

Calculated MW

23.3 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Buffer

10 mM Tris, pH 7.8 + Ammmonium S

Storage

Reconstitute in 10 mM Tris (pH 8.0) to a concentration of 0.1-1.0 mg/ml. This solution can be diluted into other aqueous buffers. Stored at -20ºC for future use.

Antigen Species

Mouse

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥95%) and by HPLC (≥95%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Gliaactivating factor, fibroblast growth factor 9, Glia-activating factor, HBGF-9, GAF, fibroblast growth factor9, FGF9, HBGF9, HBGF 9, Glia activating factor

Background

FGF-9 (also known as Glial Activating Factor) is a heparin binding growth factor that stimulates the proliferation and activation of glial cells and other cells that express FGF receptors. The rat FGF-9 is a 23.3 kDa protein containing 205 amino acid residues.

Research Area